News

Disclaimer

Disclaimer: MMV accepts no liability for the information presented here or for the consequences of any actions taken on the basis of this information.

Request for Proposal - Development of low dose primaquine tablets in a child-friendly formulation

08 Jan 2020

World Malaria report 2019 launched

04 Dec 2019

Country leaders pledge to boost malaria innovation and access to new and existing antimalarials

11 Nov 2019

Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of P. vivax malaria

31 Oct 2019

MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria

22 Oct 2019

Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives

03 Oct 2019

Tafequine featured as a key health innovation

31 Aug 2019

New maps could show how to beat malaria

24 Jun 2019

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

23 Apr 2019

New opportunities to prevent P. vivax malaria relapse

25 Feb 2019

A high risk of P. vivax after P. falciparum infection

13 Feb 2019

Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria

16 Jan 2019

Events

Jan

2020

3rd Annual Meeting of the RBM Partnership to End Malaria Multi-sectoral Working Group

6 - 7 Feb 2020

Geneva, Switzerland

Feb

2020

The Steps Beyond The Science - Paediatric Medicines For Infectious Diseases: Partnership Approaches To Accelerate Progress

The discussion focuses on the real case studies and evidence of progress made to date in advancing infectious disease treatments for paediatric populations

International Day of Women and Girls in Science 2020

7 Feb 2020

Feb

2020

Strategic Communications Partner Committee annual meeting

5th SingMalNet - Singapore Malaria Network Meeting

Areas of focus for this meeting include clinical and epidemiological research, as well as in vitro laboratory studies of the human pathogens P. falciparum and P. vivax.

20 - 21 Feb 2020

Singapore